MRNA vs SWIM · rev $145.0M vs P/E 78, rev $314.8M
Moderna Inc (MRNA) versus Latham Group Inc (SWIM) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latham Group Inc (SWIM) is a building products & equipment company listed on US.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported SWIM revenue for 2026-06-27 was $314.8M. Net income was $4.2M. SWIM currently screens at market cap $638.7M and trailing P/E 77.7.
MRNA currently screens at market cap $24.52B. SWIM currently screens at market cap $638.7M and trailing P/E 77.7.
Not investment advice. Open the MRNA and SWIM stock pages for the full models.
Not investment advice.